Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension
- PMID: 8491002
- DOI: 10.1161/01.cir.87.5.1475
Effect of increased availability of endothelium-derived nitric oxide precursor on endothelium-dependent vascular relaxation in normal subjects and in patients with essential hypertension
Abstract
Background: Patients with essential hypertension have a deficit in the endothelium-derived nitric oxide system that results in impaired endothelium-dependent vascular relaxation. The objective of this study was to determine whether this abnormality is caused by a deficiency of substrate for nitric oxide synthesis.
Methods and results: The vascular responses to acetylcholine (an endothelium-dependent vasodilator infused at 7.5, 15, and 30 micrograms/min) and sodium nitroprusside (a direct smooth muscle dilator infused at 0.8, 1.6, and 3.2 micrograms/min) were studied during combined administration of dextrose 5% or L-arginine (substrate for nitric oxide synthesis infused at 40 mumol/min) in 12 normal control subjects (seven men and five women; age, 49.3 +/- 7 years) and 14 hypertensive patients (nine men and five women; age, 48.4 +/- 7 years). In addition, the effect of D-arginine (stereoisomer of arginine that is not a precursor of nitric oxide) on the vascular responses to acetylcholine was studied in eight normal control subjects and seven hypertensive patients. Drugs were infused into the brachial artery, and the response of the forearm vasculature was measured by strain gauge plethysmography. The vasodilator response to acetylcholine was significantly blunted in hypertensive patients compared with normal control subjects (maximum flow, 8.9 +/- 5 versus 15.7 +/- 6 mL.min-1.100 mL-1, respectively; p < 0.007); however, no difference was observed in the response to sodium nitroprusside (11.4 +/- 6 and 11.7 +/- mL.min-1.100 mL-1, respectively). L-Arginine did not significantly change basal blood flow or vascular resistance in either group. In normal control subjects, the infusion of L-arginine significantly augmented the vasodilator response to acetylcholine (maximum flow, 15.7 +/- 6 versus 21.4 +/- 8 mL.min-1.100 mL-1 before and after L-arginine, respectively; p < 0.001). In contrast, in hypertensive patients, the infusion of L-arginine did not alter the response to acetylcholine (maximum flow, 8.9 +/- 5 and 8.4 +/- 4 mL.min-1.100 mL-1 before and after L-arginine, respectively). The administration of L-arginine did not modify the response to sodium nitroprusside in either group. Similarly, the infusion of D-arginine did not alter the response to acetylcholine in either group.
Conclusions: In normal humans, availability of substrate for production of nitric oxide is a rate-limiting step for endothelium-dependent vascular relaxation. In contrast, increased availability of nitric oxide precursor does not modify endothelium-mediated vasodilation in hypertensive patients. These findings provide further evidence of a defect in the endothelium-derived nitric oxide system in hypertension and indicate that this abnormality is not related to decreased availability of substrate for nitric oxide production.
Comment in
-
L-arginine in the clinical arena: tool or remedy?Circulation. 1993 May;87(5):1746-8. doi: 10.1161/01.cir.87.5.1746. Circulation. 1993. PMID: 8491028 No abstract available.
Similar articles
-
Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.Circulation. 1993 May;87(5):1468-74. doi: 10.1161/01.cir.87.5.1468. Circulation. 1993. PMID: 8491001
-
Impaired endothelium-dependent vasodilation in patients with essential hypertension. Evidence that nitric oxide abnormality is not localized to a single signal transduction pathway.Circulation. 1995 Mar 15;91(6):1732-8. doi: 10.1161/01.cir.91.6.1732. Circulation. 1995. PMID: 7882481 Clinical Trial.
-
Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients.J Am Coll Cardiol. 1994 Mar 15;23(4):844-50. doi: 10.1016/0735-1097(94)90628-9. J Am Coll Cardiol. 1994. PMID: 8106688
-
Nebivolol: endothelium-mediated vasodilating effect.J Cardiovasc Pharmacol. 2001 Dec;38 Suppl 3:S13-6. doi: 10.1097/00005344-200112003-00003. J Cardiovasc Pharmacol. 2001. PMID: 11811387 Review.
-
Endothelial function in congestive heart failure.Am Heart J. 1993 Sep;126(3 Pt 2):761-4. doi: 10.1016/0002-8703(93)90926-z. Am Heart J. 1993. PMID: 8362750 Review.
Cited by
-
Time-course and mechanisms of restored vascular relaxation by reduced salt intake and angiotensin II infusion in rats fed a high-salt diet.Microcirculation. 2009 Apr;16(3):220-34. doi: 10.1080/10739680802544177. Epub 2009 Feb 23. Microcirculation. 2009. PMID: 19235625 Free PMC article.
-
The vascular effects of L-Arginine in humans. The role of endogenous insulin.J Clin Invest. 1997 Feb 1;99(3):433-8. doi: 10.1172/JCI119177. J Clin Invest. 1997. PMID: 9022076 Free PMC article. Clinical Trial.
-
Angiotensin II Blockade and Total Cardiovascular Risk : Beyond Blood Pressure Reduction.High Blood Press Cardiovasc Prev. 2008 Oct;15(4):245-53. doi: 10.2165/0151642-200815040-00004. Epub 2013 Jan 22. High Blood Press Cardiovasc Prev. 2008. PMID: 23355127
-
Vasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaque.Heart. 2001 Sep;86(3):296-301. doi: 10.1136/heart.86.3.296. Heart. 2001. PMID: 11514482 Free PMC article.
-
The association between stress hyperglycemia and unfavorable outcomes in patients with anterior circulation stroke after mechanical thrombectomy.Front Aging Neurosci. 2023 Jan 5;14:1071377. doi: 10.3389/fnagi.2022.1071377. eCollection 2022. Front Aging Neurosci. 2023. PMID: 36688168 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous